UBS Group’s Vascular Solutions Inc VASC Stock Holding History

UBS Group’s Portfolio VASC Stock Details VASC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,239	Closed	-$237K	–	8374
2016 Q4	$237K	Buy	4,239 +1,401	+49%	+$71.4K	﹤0.01%	4676
2016 Q3	$137K	Sell	2,838 -993	-26%	-$46.3K	﹤0.01%	4796
2016 Q2	$159K	Sell	3,831 -3,484	-48%	-$130K	﹤0.01%	4700
2016 Q1	$239K	Sell	7,315 -2,109	-22%	-$60.8K	﹤0.01%	4367
2015 Q4	$324K	Sell	9,424 -697	-7%	-$23.6K	﹤0.01%	4296
2015 Q3	$328K	Buy	10,121 +1,243	+14%	+$44.5K	﹤0.01%	4238
2015 Q2	$308K	Sell	8,878 -1,866	-17%	-$60.9K	﹤0.01%	4498
2015 Q1	$326K	Sell	10,744 -4,707	-30%	-$135K	﹤0.01%	4486
2014 Q4	$420K	Buy	+15,451	New	+$419K	﹤0.01%	4349

Other funds holding VASC

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

UBS Group's VASC Position: Q1 2017 in Review

UBS Group sold out of Vascular Solutions Inc (VASC) in Q1 2017, closing a stake of 4,239 shares — an estimated $237K sold.

UBS Group first reported a position in VASC in Q4 2014 and held it in 9 quarters. The position peaked at $420K in Q4 2014. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.

UBS Group reported no remaining Vascular Solutions Inc position as of Q1 2017 after selling out during the quarter.
UBS Group sold 4,239 Vascular Solutions Inc shares in Q1 2017, an estimated $237K.
UBS Group first reported a position in Vascular Solutions Inc in Q4 2014 and held it in 9 quarters.
UBS Group's Vascular Solutions Inc position peaked at $420K in Q4 2014.
1 fund tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2017.

Based on UBS Group's 13F filing for Q1 2017, filed 12 May 2017.